University of Vermont

College of Medicine

Vermont Cancer Center

symp_speakers

Clinical & Translational Research Symposium

Molecular and Behavioral Cancer Epidemiology

Friday, November 21, 2014
Davis Auditorium
The University of Vermont Medical Center
Burlington, VT

Speakers

Guest Faculty:  
Susan Hankinson, ScD, MPH, MS

Susan Hankinson, ScD, MPH, MS
Professor of Epidemiology
University of Massachusetts at Amherst
*Juckett Keynote Speaker

Dr. Hankinson received Master’s degrees in both environmental health and epidemiology from the University of Minnesota. She obtained a doctoral degree in epidemiology from the Harvard School of Public Health. In addition to her work at the University of Massachusetts at Amherst, Dr. Hankinson has played key roles at Brigham and Women's Hospital and Harvard Medical School, serving as coleader of the Cancer Research Center at the latter's Biomedical Research Institute.

Margaret Karagas, PhD

Margaret Karagas, PhD
Professor of Community and Family Medicine
Geisel School of Medicine at Dartmouth

Dr. Karagas received her PhD from the University of Washington in 1990. Her current research includes several epidemiological studies focusing on the etiologic mechanisms and prevention of human cancers and other adverse health outcomes. Another aspect of this research is a population-based case-control study of these malignancies designed to quantify the risks associated with emerging exposures such as tanning lamps, ingestion of arsenic-containing drinking water, immunosuppressive therapy and other factors. The research has been extended to study the effects of arsenic on bladder cancer and to conduct chemical analyses of household drinking water supplies. Her work also includes studies of melanoma among women and collaborative investigations of markers of individual susceptibility and biological response to environmental agents.

Lorelei Mucci, ScD, MPH

Lorelei Mucci, ScD, MPH
Associate Professor of Epidemiology
Harvard School of Public Health

Dr. Mucci received ger MPH from the Boston University School of Public Health in 1998 and her ScD from the Harvard School of Public Health in 2003. Her major research focuses on the epidemiology of prostate cancer risk and progression within cohorts of men from the United States and Scandinavia, with an emphasis on cancer biomarker studies, including circulating markers, inherited genetic alleles, as well as tumor biomarkers.

Michael Pollak, MD

Michael Pollak, MD
Director, Division of Cancer Prevention
Alexander-Goldfarb Research Chair in Medical Oncology
Professor of Medicine and Oncology
Director of Cancer Prevention Centre
McGill University and Segal Cancer Centre

Dr. Pollak is an internationally recognized expert in cancer endocrinology. His research focuses on the roles of insulin and insulin-like growth factors in cancer biology, and he has been the principal investigator on several pivotal clinical trials of new drugs. Dr Pollak holds the Alexander Goldfarb Research Chair in cancer research at McGill University, Montreal, Canada, and directs the Division of Cancer Prevention of the Department of Oncology. He practices medical oncology at the Jewish General Hospital in Montreal, and also runs a research lab at the Lady Davis Research Institute, which is affiliated with the Hospital and McGill. He received one of Quebec’s top scientific honors, the Chercheur national award from the Fonds de Recherche Santé Quebec and has published more than 300 research papers.

Kristin Wallace, PhD

Kristin Wallace, PhD
Assistant Professor of Public Health Sciences
Medical University of South Carolina

Dr. Wallace received her PhD and postdoctoral training at Dartmouth Medical School. She trained as a cancer epidemiologist with expertise in colorectal neoplasia. Her research interests include cancer epidemiology, racial disparities, and colorectal neoplasia.

Internal Faculty:  
Thomas Ahern, PhD, MPH

Thomas Ahern, PhD, MPH
Assistant Professor of Surgery
University of Vermont
University of Vermont Cancer Center Member

Thomas Ahern is an assistant professor in the departments of surgery and biochemistry at the University of Vermont. His research concerns the molecular- and pharmaco-epidemiology of breast cancer risk and survival, and he is currently funded by Susan G. Komen for the Cure to examine the impact of chronic phthalate exposure on breast cancer risk. In addition to his research, Dr. Ahern teaches courses on epidemiologic methods in the U.S. and Finland.

Bernard Cole, PhD

Bernard Cole, PhD
Professor of Statistics
University of Vermont

University of Vermont Cancer Center Member

Dr. Cole is Professor of Statistics in the Department of Mathematics and Statistics at the University of Vermont. His career as a biostatistician spans two decades and is distinguished by over 150 articles, books, and editorials in the statistical and biomedical literature. Cole’s major area of research involves statistical methods for quality-of-life studies in cancer clinical trials. His other research activities involve cancer epidemiology and chemoprevention studies. He is a member of the International Breast Cancer Study Group , serves on the editorial board of the Journal of the National Cancer Institute, and he is a member of the Oncologic Drugs Advisory Committee of the US Food and Drug Administration.

Brian Sprague, PhD

Brian Sprague, PhD
Assistant Professor of Surgery
University of Vermont College of Medicine
University of Vermont Cancer Center Member

Dr. Brian Sprague, PhD, is an Assistant Professor in the Department of Surgery at the University of Vermont. As a cancer epidemiologist he conducts population-level research on breast cancer incidence, detection, and survival. He leads the Vermont Breast Cancer Surveillance System, a member of the national Breast Cancer Surveillance Consortium, which studies risk-based breast cancer screening strategies. He is currently co-Principal Investigator of the Vermont PROSPR Research Center, which seeks to evaluate the breast cancer screening process and identify factors associated with recurrence after an early stage breast cancer diagnosis.

More Information:
To register or for more information, please contact:

Charles Brooks, events coordinator
The University of Vermont Cancer Center
Courtyard at Given N-419
89 Beaumont Avenue
Burlington, VT 05405
(802) 656-2176
Contact by Email

Last modified November 13 2014 09:00 AM